2023-10-23T03:11:04+03:00[Europe/Moscow] en true <p>cure</p>, <p>cisplatin + etoposide + radiation x 4 cycles </p>, <p>false; only extensive</p>, <p>carboplatin + etoposide + atezolizumab/durvalumab x 4 cycles</p>, <p>atezolizumab/durvalumab</p>, <p>3-5 day cycle; targets cells in G2 phase</p>, <p>2-3 cycles</p>, <p>physical exam + CT chest scan every 3-4 months for 2 years; then every 6 months for 3 years; then annually </p> flashcards
Small Cell (Therapeutics)

Small Cell (Therapeutics)

Customize
collection saved
Share
Long Term Learning Spaced Repetition
Add to Long Term Learning Desk
Fast learning Repeat this set of flashcards
Preview Test Spell
Play
Match
Review

  • cure

    What is the goal of treating limited-stage SCLC?

  • cisplatin + etoposide + radiation x 4 cycles

    What is the treatment for Limited-Stage SCLC?

  • false; only extensive

    Maintenance therapy is recommended in Extensive & Limited-Stage. T/F?

  • carboplatin + etoposide + atezolizumab/durvalumab x 4 cycles

    What is the treatment for Extensive SCLC?

  • atezolizumab/durvalumab

    What is the maintenance therapy for Extensive?

  • 3-5 day cycle; targets cells in G2 phase

    How often is Etoposide given? Why?

  • 2-3 cycles

    How often do we monitor tumor response in extensive?

  • physical exam + CT chest scan every 3-4 months for 2 years; then every 6 months for 3 years; then annually

    How does long-term follow-up work? (3)